SARS-CoV-2 vaccination induces breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria on complement inhibitor.

Fattizzo, Bruno; Giannotta, Juri Alessandro; Cecchi, Nicola; Barcellini, Wilma

Fattizzo, Bruno; Giannotta, Juri Alessandro; Cecchi, Nicola; Barcellini, Wilma.

Fattizzo B; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Giannotta JA; Department of Oncology and Oncohematology, University of Milan, Milan, Italy.
Cecchi N; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Barcellini W; Department of Oncology and Oncohematology, University of Milan, Milan, Italy.

Am J Hematol ; 96(9): E344-E346, 2021 09 01.

Article in English | MEDLINE | ID: covidwho-1245345

Subject(s)

COVID-19/blood; COVID-19/virology; Clonal Hematopoiesis; SARS-CoV-2; Angiotensin-Converting Enzyme 2/metabolism; Biomarkers; COVID-19/complications; COVID-19/diagnosis; Cytokine Release Syndrome/blood; Cytokine Release Syndrome/etiology; Disease Progression; Host-Pathogen Interactions; Humans; Leukocytes/immunology; Leukocytes/metabolism; SARS-CoV-2/physiology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Clonal Hematopoiesis / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Language: English Journal: Am J Hematol Year: 2021 Document Type: Article Affiliation country: Ajh.26262

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google